
Nephrologists can expect some new IV iron and phosphate binder products to be launched this year

Nephrologists can expect some new IV iron and phosphate binder products to be launched this year

The Academy of Managed Care Pharmacy expands on its document on medication therapy management

ImaRx Therapeutics' urokinase gains an additional 20 months of expiration dating

CMS proposes rule to revise DMEPOS supplier standards

Report finds infant formula under scrutiny for alleged dangerous additives

The National Community Pharmacists Association urges Wal-Mart to uphold quality standards in its pharmacy benefit management business

URAC is planning to set up a program to accredit specialty pharmacies, pharmacy benefit management for workers compensation, and mail-order pharmacy

Pharmacy associations support FDA toll-free number for reporting adverse events rule

CMS announces second phase of Medicare competitive bidding program for DMEPOS

A proposed rule from the Centers for Medicare & Medicaid Services encourages prescription drug plans to offer reduced premium plans for low-income subsidized patients.

FDA warns compounding pharmacies to stop using estriol

There are new guidelines issued by NCCN that make recommendations on how to treat multiple myeloma.

Pharmacists evaluate potential drug interactions in patient with atrial fibrillation.

Researchers evaluated new approaches to managing major bleeding and clotting diseases.

Physicians who prescribe patients more than three days of antibiotics may be doing more harm than good.

New guidelines have been issued related to the use of perioperative drugs for cardiac patients.

Cedars-Sinai Medical Center takes steps to prevent the heparin drug error, which befell Dennis Quaid's twins.

From pharmacy automation to environmentally friendly drug disposal solutions, many new technology products are on display at the ASHP show.

Novation is offering a new service to help member hospitals recover their supply chain dollars.

Speakers at the AMCP meeting give suggestions on how more hospitals can make use of the 340B program.

The revision emphasizes training and competency of pharmacists.

Drug samples should be replaced by vouchers to reduce drug diversion; chemistry courses are critical to the education of pharmacy students.

DEA's new rule allowing multiple prescriptions for Schedule II controlled substances could engender greater Rx drug abuse.

The risk for fatal medication errors is highlighted in an important new warning within a revised produt label for Heparin Sodium Injection.

Combo drugs are driving drug development in hypertension these days.

Regional groups are forming to set up standards for experiential training of students.

Does the lactose content of medications pose a problem in patients who are lactose intolerant?

Hy-Vee joins The Caregivers Marketplace as official retail outlets

Diabetes is taking a greater toll